Press Releases
Settlement-delivery of the share capital increase by EOS imaging for an amount of €15M entirely subscribed by FOSUN PHARMACEUTICAL AG
EOS imaging announced in a press release dated December 7th, 2018 the completion of a share capital increase (the "Share Capital Increase") for an amount of €15,061,856.13 through the issuance of 3,446,649 new shares at a subscription price of €4.37 per share entirely subscribed by Fosun Pharmaceutical AG, an indirect subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma, stock code: 600196.SH, 02196.HK).
Completion of a share capital increase by EOS imaging for an amount of €15M entirely subscribed by FOSUN PHARMACEUTICAL AG
EOS imaging received the required Chinese regulatory authorizations and announces today having received the visa of the AMF number 18-551 on the prospectus relating to the Share Capital Increase.
EOS imaging to present its EOSapps suite at the French Society of Orthopedic and Traumatological Surgery Congress (SOFCOT)
- Symposium to showcase Total Hip Arthroplasty (THA) results with EOS analysis
- First time association of hipEOS with intra-operative navigation to execute surgical plan
EOS imaging LEADERSHIP TRANSITION TO STRENGTHEN U.S. STRATEGY
-Mike Lobinsky, President North America, appointed Chief Executive Officer effective January 1, 2019
-Valérie Worrall joins as Chief Financial Officer
EOS imaging will present the EOS Solution at the American Association of Hip and Knee Surgeons (AAHKS) meeting, November 1-4 in Dallas, Texas
Booth presentation on THA planning from EOS images by Dr. Mayman, Orthopedic Surgeon and Clinical Co-Director, Computer Assisted Surgery Center at the Hospital for Special Surgery on Friday, November 2nd at 1:45 pm in booth #521
EOS imaging announces installations of first EOS® systems in Spain and Portugal
- First two EOS systems in Spain installed in Barcelona
- Installation planned short term in Portugal
EOS imaging reports third quarter 2018 sales
Continued momentum in Asia-Pacific and North America, offset by delayed timing of capital sales in EMEA
EOS imaging will present its EOS solution for patient-specific treatment at the francophone radiology days (JFR) congress in paris
- stereoVIEW, a software dedicated to clinical collaboration and patient engagement, and the new EOS online learning platform will be demonstrated at EOS Booth #113
- Results from a study on 3D spine reconstruction using deep learning (artificial intelligence) will be presented for the first time
EOS imaging SHOWCASES hipEOS AT THE INTERNATIONAL SOCIETY FOR TECHNOLOGY IN ARTHROPLASTY (ISTA) IN LONDON
Internationally recognized leaders in total hip arthroplasty (THA) to present the value of EOS along the hip care pathway through 7 podium presentations and 3 posters
EOS imaging to showcase the EOS solution at the 2018 North American Spine Society (NASS) Annual Meeting September 26-29, 2018 in Los Angeles
spineEOS, part of the EOSapps suite of online 3D surgical planning solutions, will be presented by a renowned surgeon in EOS Booth #2314
EOS imaging reports first half 2018 financial results
- +11% sales growth driven by positive momentum in North America and Asia-Pacific regions, tampered by forex effects (+7% including forex impact)
- 520 points increase in gross margin to 50.3% of sales
- Strengthened cash position following issuance of convertibles and financing agreement with Fosun(1)
EOS imaging installs its first site in Mexico
The company expands its geographic presence to the largest Central American market from its North American subsidiary
EOS imaging achieves its 100th installation in the United States
Methodist Dallas Medical Center represents the 10th installation in Texas
Milestones reflect growing adoption of EOS technology as a standard of care in orthopedics
EOS imaging and Fosun Pharmaceutical AG enter into an agreement for a significant equity investment
EOS imaging today announced that it entered into a binding agreement with Fosun Pharmaceutical AG, an indirect subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma, stock code: 600196.SH, 02196.HK), related to an equity investment to be made by Fosun Pharmaceutical AG through an issuance of EOS imaging news shares.
EOS imaging announces First Half 2018 Sales of €17.5 Million supported by strong growth in Asia-Pacific and North America
EOS imaging today announced its non-audited consolidated sales revenue for the six months ended June 30, 2018
University Hospital Center of Grenoble Alpes (CHUGA) becomes the 20th University Hospital equipped with the EOS® system in France
The equipment will be dedicated to pediatric and adult care and to the development of innovative orthopedic treatments
EOS imaging announces first private practice installation of an EOS® system in Germany
ATOS Klinik Heidelberg’s specialized spine center, Zentrum für Wirbelsäulenchirurgie, adopts EOS® low-dose, 2D/3D full-body imaging system
EOS imaging Announces US FDA Clearance for hipEOS 3.0 Software
EOS imaging announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its hipEOS 3.0 surgical planning software.
EOS imaging announces the success of its offering of bonds convertible into new shares and/or exchangeable for existing shares (“OCEANES”)
EOS imaging announces the success of its offering of bonds convertible into new shares and/or exchangeable for existing shares (“OCEANES”) due 2023 for an amount of €29.5 million
EOS imaging launches an offering of bonds convertible into new shares and/or exchangeable for existing shares (“OCEANES”)
EOS imaging announces today the launch of an offering of bonds convertible into new shares and/or exchangeable for existing shares (“OCEANEs”)
EOS imaging announces 15th installation in Australia
The Queensland X-Ray practice in Gold Coast Private Hospital marks the 13th installation in a private facility in Australia
EOS imaging COMMUNICATES ITS ANNUAL REPORT 2017
Review of significant events of 2017 and first quarter of 2018
Discussion of financing outlook
EOS imaging announces new EOS® system installations in two U.S. private orthopedic practices
EOS imaging announced that University Orthopedics in Providence, Rhode Island, and the Hey Clinic for Scoliosis and Spine Surgery in Raleigh, NC, have installed the EOS® system for low-dose, 2D and 3D imaging of patients.
EOS imaging reports 1st quarter 2018 revenue growth of 34% and full year 2017 results
EOS imaging today announces its first quarter 2018 consolidated sales revenue and consolidated results for the full year ended December 31, 2017, as adopted by the Board of Directors on April 11, 2018
EOS imaging previews stereoVIEW for comprehensive multidisciplinary clinical collaboration and patient engagement
EOS imaging will be showcasing stereoVIEW, hipEOS 3.0 (FDA Pending), and the rest of EOSapps at the 2018 American Academy of Orthopedic Surgeons (AAOS) Annual Meeting
EOS imaging announces first system installation within Asklepios Private Hospital Group in Germany
The second largest private hospital group in Germany adopts EOS® for its Asklepios Paulinen Hospital
EOS imaging announces new installation in a top-ranking specialty orthopedic hospital in China
Beijing Jishuitan Hospital adopts the EOS® low dose, 2D/3D orthopedic imaging system
EOS imaging Reports Full Year 2017 Sales Up 21% to €37.1 Million
North America fourth quarter sales increased 53% (in USD)